Volume V, Issue 23

June 4, 2018
'End of an Era' for Chemo in Non-Small Cell Lung Cancer    
Liam Davenport reports for Medscape on June 03, 2018 that most patients with advanced non-small cell lung cancer (NSCLC) can now avoid having chemotherapy as a first-line treatment, after a large, randomized trial showed that immunotherapy with the programmed cell death ligand 1 (PD-L1) blocker pembrolizumab ( Keytruda, Merck) is effective even in patients with minimal PD-L1 expression.

The findings could double the population of patients with advanced NSCLC eligible to receive first-line immunotherapy alone and were hailed as a "true milestone" by experts here at the American Society of Clinical Oncology (ASCO) 2018 <Chicago>, according to the article. 
Log in/Complimentary Subscription Required
Hospital addresses social determinants of health via partnership
In a 6.2.18 Modern Healthcare post, we learn how Nationwide Children's Hospital, Columbus, Ohio's safety-net provider for low-income children, has successfully partnered with Community Development for All People, a Columbus, Ohio-based not-for-profit organization, that is devoted to improving social and economic conditions for residents of the city's South Side.

Only a handful of health systems have begun to look beyond the clinical to delve into how societal conditions
affect the health outcomes of their patient populations. You can read about one such experiment in this article.
Log in/Complimentary Subscription Required
American Cancer Society: Begin Colorectal Screening at Age 45
The American Cancer Society (ACS) released an updated guideline for colorectal cancer screening on 5.30.18. Among the major guideline changes, the new recommendations say screening should begin at age 45 for people at average risk. Previously, the guideline recommended screening 
5.30.18 CBS News
CBS News
  begin at age 50 for people at average risk. Recommendations for screening test options are also part of the guideline changes.

Analysis of data shows that new cases of colorectal cancer are occurring at an increasing rate among younger adults.



About Us
Florida Health Industry Week in Review is published every Monday by

Each Monday morning, we share the top healthcare headlines of the previous week and summarize
What Happened (WH) and
Why It Matters (WIM).

To learn how you can join our team of editorial contributors, contact Jeffrey Herschler .

Inside FloridaHealthIndustry.com